Citation Impact
Citing Papers
Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]
2007
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Predominant Autoantibody Production by Early Human B Cell Precursors
2003 StandoutScience
ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology.
1999
Controlled Trials of Antibiotic Treatment in Patients with Post-Treatment Chronic Lyme Disease
2002
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
UV Light Potentiates STING (Stimulator of Interferon Genes)-dependent Innate Immune Signaling through Deregulation of ULK1 (Unc51-like Kinase 1)
2015 StandoutNobel
Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis
2011
Systemic Sclerosis Sine Scleroderma: A Multicenter Study of 1417 Subjects
2014
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis
2007
Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial
2010
Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase
2014
A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies
2003 Standout
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Psoriasis
2009 Standout
Long‐term prospective trial of low‐dose methotrexate in rheumatoid arthritis
1988
Small-Vessel Vasculitis
1997 Standout
Rheumatoid arthritis
2016 Standout
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
2014
Pathogenesis of human systemic lupus erythematosus: recent advances
2010
The β-Thalassemias
1999 Standout
Chronic Lyme Disease: A Review
2008
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
The american college of rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis
1992
Detection of Attenuated, Noninfectious Spirochetes inBorrelia burgdorferi–Infected Mice after Antibiotic Treatment
2002
Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America
2010
Antibiotic Treatment Duration and Long‐Term Outcomes of Patients with Early Lyme Disease from a Lyme Disease–Hyperendemic Area
2010
Modified-release sildenafil reduces Raynaud's phenomenon attack frequency in limited cutaneous systemic sclerosis
2011
Prevalence and clinical correlates of pruritus in patients with systemic sclerosis: an updated analysis of 959 patients
2013
Digital ulcers predict a worse disease course in patients with systemic sclerosis
2015
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians
2010
American college of rheumatology preliminary definition of improvement in rheumatoid arthritis
1995 Standout
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
2015
Elucidating the burden of recurrent and chronic digital ulcers in systemic sclerosis: long-term results from the DUO Registry
2015
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
2014
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
How Can We Prevent Lyme Disease?
2003
Maternal Lyme borreliosis and pregnancy outcome
2009
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Systemic sclerosis
2017 Standout
The American college of rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials
1993 Standout
Lyme Disease
2001
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease
1997 Standout
Assessment of Quality-of-Life Outcomes
1996 Standout
A Critical Appraisal of “Chronic Lyme Disease”
2007
Lyme borreliosis: Clinical case definitions for diagnosis and management in Europe
2010
Calcium signaling in systemic lupus erythematosus T cells: A treatment target
2011
Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study
2007
The Timed “Up & Go”: A Test of Basic Functional Mobility for Frail Elderly Persons
1991 Standout
Nervous system Lyme disease
1998
Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus
2005
Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: Application of a latent linear trajectory model
2007
Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis
2000
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Disease severity in rheumatoid arthritis: Relationships of plasma tumor necrosis factor-?, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures
1992
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
2010
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
1999
Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research
2008
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials
1997 Standout
A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma
2001
Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms
2005
Wegener Granulomatosis: An Analysis of 158 Patients
1992 Standout
Antibodies to DNA
1998
Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications
1996
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Targeting BAFF in autoimmunity
2010
Crohn's disease
2016 Standout
Ankylosing spondylitis
2007 Standout
Inflammatory Bowel Disease
2002 Standout
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma
2004
Psychological States and Neuropsychological Performances in Chronic Lyme Disease
1999
Should imporvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?
1998
Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty‐eight–week randomized, double‐blind trial
1991
Systemic Lupus Erythematosus
2011 Standout
EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis
2009
Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate
2006
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis
2013
SLE and Infections
2003
Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)
2011
Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms
2010
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
2011
Nutritional status measured by BMI is impaired and correlates with left ventricular mass in patients with systemic sclerosis
2014
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression
2004
Autoantibodies as predictors of disease
2001
Gabapentin for the Symptomatic Treatment of Chronic Neuropathic Pain in Patients with Late-Stage Lyme Borreliosis: A Pilot Study
2005
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Role of psychiatric comorbidity in chronic Lyme disease
2008
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Rheumatoid arthritis
2010 Standout
Complement
2001 Standout
Health Status Assessment for Elderly Patients
1989
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
2010
AIMS2. The Content and Properties of a Revised and Expanded Arthritis Impact Measurement Scales Health Status Questionnaire
1992 Standout
Long-term follow-up of patients with culture-confirmed lyme disease
2003
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
A 58-Year-Old Man With a Diagnosis of Chronic Lyme Disease
2002
Observational Study of Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
2009
Effect Sizes for Interpreting Changes in Health Status
1989 Standout
Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials
1988
Lyme borreliosis
2003
Early Lyme Disease
2006
Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial
2008
Methotrexate for the Treatment of Crohn's Disease
1995
Lyme borreliosis
2011 Standout
A randomized, controlled trial of arthroscopic surgery versus closed‐needle joint lavage for patients with osteoarthritis of the knee
1993
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
2002 Standout
Gene expression changes reflect clinical response in a placebo-controlled randomized trial of abatacept in patients with diffuse cutaneous systemic sclerosis
2015
The PHQ-9
2001 Standout
Systemic sclerosis
2015
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Amyotrophic Lateral Sclerosis
2001 Standout
Prediction of improvement in skin fibrosis in diffuse cutaneous systemic sclerosis: a EUSTAR analysis
2016
The comparative efficacy and toxicity of second‐line drugs in rheumatoid arthritis results of two metaanalyses
1990
Lyme borreliosis in Europe and North America
2004
Prospective Study of Serologic Tests for Lyme Disease
2008
Microbiological and serological diagnosis of Lyme borreliosis
2006
Reassessment of Twelve Traditional Paradigms Concerning the Diagnosis, Prevalence, Morbidity and Mortality of Rheumatoid Arthritis
1989
Subjective Symptoms after Treatment of Early Lyme Disease
2009
Evaluation of Study Patients with Lyme Disease, 10–20‐Year Follow‐up
2001
The emergence of Lyme disease
2004
Misconceptions about Lyme Disease: Confusions Hiding behind Ill-Chosen Terminology
2002
In Vitro Susceptibility Testing ofBorrelia burgdorferiSensu Lato Isolates Cultured from Patients with Erythema Migrans before and after Antimicrobial Chemotherapy
2005
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
1986
Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
1999
The functional status questionnaire
1986
Coordinative Alignment in the Pores of MOFs for the Structural Determination of N-, S-, and P-Containing Organic Compounds Including Complex Chiral Molecules
2019 StandoutNobel
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy
2007
Laboratory Evaluation in the Diagnosis of Lyme Disease
1997
Diagnosis of Lyme Borreliosis
2005
Measurement of Health Status in Diabetic Patients: Diabetes Impact Measurement Scales
1992
Macrolide therapy of chronic Lyme Disease.
2003
T Cell Studies in a Peptide-Induced Model of Systemic Lupus Erythematosus
2001 StandoutNobel
Standards for validating health measures: Definition and content
1987
A Brief Measure for Assessing Generalized Anxiety Disorder
2006 Standout
Modifying Lipophilicities of Zn(II) Coordination Species by Introduction of Ancillary Ligands: A Supramolecular Chemistry Approach
2010
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
1985
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.
1992 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
Increased Frequency of Pre-germinal Center B Cells and Plasma Cell Precursors in the Blood of Children with Systemic Lupus Erythematosus
2001
Clinical Manifestations and Diagnosis of Lyme Borreliosis
2009
Recombinant Human Relaxin in the Treatment of Scleroderma
2000
Metal–Organic Frameworks in Biomedicine
2011 Standout
Systemic lupus erythematosus
2007
ACTIVATION OF THE COMPLEMENT AND PROPERDIN SYSTEMS IN RHEUMATOID ARTHRITIS*
1975
The Biology and Detection of Immune Complexes
1980
A systemic lupus erythematosus gene expression array in disease diagnosis and classification: a preliminary report
2010
Study and treatment of post Lyme disease (STOP-LD)
2003
Duration of Antibiotic Therapy for Early Lyme Disease
2003
Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
2017
Iron-Chelating Therapy and the Treatment of Thalassemia
1997
Inaccurate Information About Lyme Disease on the Internet
2004
The Transcriptional Repressor cAMP Response Element Modulator α Interacts with Histone Deacetylase 1 to Repress Promoter Activity
2006
Clinical Characteristics and Treatment Outcome of Early Lyme Disease in Patients with Microbiologically Confirmed Erythema Migrans
2002
Works of Arthur Weinstein being referenced
Increased Levels of NF-ATc2 Differentially Regulate CD154 and IL-2 Genes in T Cells from Patients with Systemic Lupus Erythematosus
2007
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon
2002
Molecular mimicry between bacterial and self antigen in a patient with systemic lupus erythematosus
1999
Maternal Lyme disease and congenital malformations: a cord blood serosurvey in endemic and control areas
1995
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: Analysis of a two-year, double-blind, randomized, controlled clinical trial
1999
Novel evidence‐based systemic lupus erythematosus responder index
2009
Western blot band intensity analysis. Application to the diagnosis of lyme arthritis
1994
The fibromyalgia impact questionnaire: A useful tool in evaluating patients with post-Lyme disease syndrome
1999
Dermatomyositis Associated with Lyme Disease: Case Report and Review of Lyme Myositis
1994
Scientific evidence and best patient care practices should guide the ethics of Lyme disease activism: Table 1
2010
Intralaboratory reliability of serologic and urine testing for Lyme disease
2001
Two Controlled Trials of Antibiotic Treatment in Patients with Persistent Symptoms and a History of Lyme Disease
2001
Partial H (?1H) deficiency and glomerulonephritis in two families
1982
Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis.
1995
Low‐Dose D‐Penicillamine Therapy in Rheumatoid Arthritis
1983
Randomized, Double‐Blind, Placebo Controlled Trial of Low‐Dose Pulse Methotrexate in Psoriatic Arthritis
1984
Metabolism of the third component of complement (C3) in patients with rheumatoid arthritis
1972
Low dose methotrexate in rheumatoid arthritis.
1983
Outcome assessment in clinical trials evidence for the sensitivity of a health status measure
1984
Differential Expression and Molecular Associations of Syk in Systemic Lupus Erythematosus T Cells
2008
Cyclic Adenosine 5′-Monophosphate Response Element Modulator Is Responsible for the Decreased Expression of c-fos and Activator Protein-1 Binding in T Cells from Patients with Systemic Lupus Erythematosus
2004
Letters
1991
A comparison of the sensitivity of the 1971 and 1982 american rheumatism association criteria for the classification of systemic lupus erythematosus
1984
Clinical and neurocognitive features of the post Lyme syndrome.
1996
Azathioprine versus d‐penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold
1984
Systemic lupus erythematosus in the younger patient: survival studies.
1980
Low-dose methotrexate treatment of rheumatoid arthritis. Long-term observations
1985
Antibodies to native DMA and serum complement (C3) levels
1983
Drug-induced systemic lupus erythematosus
1969
Cognitive function in post-treatment Lyme disease Do additional antibiotics help?
2003
Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis
1983